ZIVO BIOSCIENCE, INC.: 10-K filed 2014-03-31
What ZIVO BIOSCIENCE, INC. reported in its annual report filed 2014-03-31 (fiscal FY 2013): 28 published measures, 56 facts as tagged in accession 0001078782-14-000496.
This filing
- Form
- 10-K (annual report)
- Filed
- 2014-03-31
- Fiscal period
- fiscal FY 2013
- Accession
- 0001078782-14-000496 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ZIVO BIOSCIENCE, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 2,174,403 | USD | |
| At 2012-12-31 | 234,004 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 11,768,263 | USD | |
| At 2012-12-31 | 4,190,195 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | -9,593,860 | USD | |
| At 2012-12-31 | -3,956,191 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 493,103 | USD | |
| At 2012-12-31 | 47,147 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | -10,095,878 | USD | 364 |
| 2012-01-02 to 2012-12-31 | -3,248,405 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | -2,986,214 | USD | 364 |
| 2012-01-02 to 2012-12-31 | -1,773,264 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 0 | USD | 364 |
| 2012-01-02 to 2012-12-31 | -3,500 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 0 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 0 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 3,763,547 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 1,598,215 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | -331,377 | USD | 364 |
| 2012-01-02 to 2012-12-31 | -3,500 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | -42,606,092 | USD | |
| At 2012-12-31 | -32,510,214 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 93,750 | USD | |
| At 2012-12-31 | 13,203 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | -3,110,197 | USD | 364 |
| 2012-01-02 to 2012-12-31 | -2,080,593 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 688,527 | USD | |
| At 2012-12-31 | 90,805 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | -441,477 | USD | 364 |
| 2012-01-02 to 2012-12-31 | -141,734 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 10,877,452 | USD | |
| At 2012-12-31 | 3,361,287 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 483,208 | USD | |
| At 2012-12-31 | 938,640 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 0 | USD | |
| At 2012-12-31 | 6,234 | USD |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 0 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 0 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 1,018,023 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 677,490 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 116,852,093 | shares | |
| At 2012-12-31 | 105,317,816 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 32,895,380 | USD | |
| At 2012-12-31 | 28,448,705 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-12-31 | 738,686 | USD | |
| At 2012-12-31 | 270,682 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | -10,095,878 | USD | 364 |
| 2012-01-02 to 2012-12-31 | -3,248,405 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 1,189,812 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 938,198 | USD | 365 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 0 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 0 | USD | 365 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | 0 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 50 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-02 to 2013-12-31 | -455,432 | USD | 364 |
| 2012-01-02 to 2012-12-31 | 278,075 | USD | 365 |
Inspect the source
- Entity
- ZIVO BIOSCIENCE, INC. / CIK 0001101026
- Captured
- 2026-09-20T05:23:02.675Z
- SEC response SHA-256
a67c6f73387834b08f1985c02ad3ba915b8082582e19652219d78b25a60d946c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001101026.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))